Home › Kanser sa Cervix › Kentucky
Pag-aaral pangklinika para sa Kanser sa Cervix sa Kentucky
7 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa Kentucky.
Mga Lungsod sa Kentucky
Opisyal na teksto ng pag-aaral (English)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Norton Cancer Institute - Downtown, Louisville
- Norton Hospital, Louisville
- Norton Cancer Institute St Matthews Campus, Louisville
- at 1 pa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Norton Cancer Institute, Louisville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Baptist Health Lexington, Lexington
- Baptist Health, Lexington
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 30, 2026 · NCT04831580Hypofractionated Radiochemotherapy
- Markey Cancer Center, Lexington
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Kababaihan · Na-update Hul 30, 2026 · NCT06331468Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- UK Markey Cancer Center, Lexington
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05283330cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT05366881A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 115, Louisville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.